Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Cash from Investing Activities (2016 - 2026)

Lexaria Bioscience's Cash from Investing Activities history spans 12 years, with the latest figure at -$53909.0 for Q1 2026.

  • Quarterly results put Cash from Investing Activities at -$53909.0 for Q1 2026, down 93.26% from a year ago — trailing twelve months through Feb 2026 was -$236329.0 (down 50.25% YoY), and the annual figure for FY2025 was -$243019.0, down 28.85%.
  • Cash from Investing Activities for Q1 2026 was -$53909.0 at Lexaria Bioscience, down from -$5099.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$5099.0 in Q4 2025 to a low of -$157878.0 in Q3 2025.
  • The 5-year median for Cash from Investing Activities is -$37804.0 (2024), against an average of -$46039.2.
  • The sharpest move saw Cash from Investing Activities plummeted 2502150.0% in 2022, then skyrocketed 86.51% in 2025.
  • Year by year, Cash from Investing Activities stood at -$34842.0 in 2022, then decreased by 14.88% to -$40026.0 in 2023, then increased by 5.55% to -$37804.0 in 2024, then skyrocketed by 86.51% to -$5099.0 in 2025, then tumbled by 957.25% to -$53909.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$53909.0, -$5099.0, and -$157878.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.